










































































































Patients With Chronic Spinal Pain Benefit From Pain Neuroscience
Education Regardless the Self-Reported Signs of Central
Sensitization: Secondary Analysis of a Randomized Controlled
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146Background: Pain neuroscience education is effective in chronic pain management. Central sensitization (ie, generalized hy-
persensitivity) is often explained as the underlying mechanism for chronic pain, because of its clinical relevance and influence on
pain severity, prognosis, and treatment outcome.
Objectives: To examine whether patients with more or fewer symptoms of central sensitization respond differently to pain
neuroscience education.
Design: A secondary analysis of a multicenter, triple-blind randomized controlled trial.
Setting: University hospital Ghent and University Hospital Brussels, Belgium.
Patients: 120 persons with chronic spinal pain with high or low self-reported symptoms of central sensitization.
Interventions: Pain neuroscience education or neck/back school. Both interventions were delivered in 3 sessions: 1 group session,
1 online session, and 1 individual session.
Main Outcome Measures: disability (primary), pain catastrophizing, kinesiophobia, illness perceptions, and hypervigilance.
Results: Pain disability did not change in any group (P ¼ .242). Regarding secondary outcomes: significant interaction effects were
found for pain catastrophizing (P-values: P ¼ .02 to P ¼ .05), kinesiophobia (P ¼ .02), and several aspects of illness perceptions
(chronicity: P ¼ .002; negative consequences: P ¼ .02; personal control: P ¼ .02; and cyclicity: P ¼ .02). Bonferroni post hoc
analysis showed that only the pain neuroscience education group showed a significant improvement regarding kinesiophobia
(P < .001, medium effect sizes), perceived negative consequence (P ¼ .004 and P < .001, small to medium effect sizes), and
perceived cyclicity of the illness (P ¼ .01 and P ¼ .01, small effect sizes).
Conclusion: Pain neuroscience education is useful in all patients with chronic spinal pain as it improves kinesiophobia and the
perceived negative consequences and cyclicity of the illness regardless the self-reported signs of central sensitization. Regarding
pain catastrophizing, pain neuroscience education is more effective in patients with high self-reported symptoms of central
sensitization.
Level of Evidence: Level I, therapy










In the last decade the focus of educational programs
for people with chronic pain has shifted remarkably to
pain neuroscience education [1-5]. Pain neuroscience
education is used to increase the patients’ knowledge of
the underlying pain physiology, to decrease the threatFLA 5.5.0 DTD  PMRJ2106_
1934-1482/$ - see front matter ª 2018 by the American Academy of Physi
https://doi.org/10.1016/j.pmrj.2018.04.010value of pain, and to reconceptualize pain [6,7]. Neuro-
physiological mechanisms of the peripheral and central
nervous system and neuroplastic changes occurring in
case of chronic pain are explained in layman’s terms,
using photographs, drawings, metaphors, etc. Particular
attention is given to the brain, and its role in pain related
thoughts, attitudes and psychological distress, whichproof  25 May 2018  4:06 pm  ce





































































































































































320influence pain perception [8]. There is some evidence to
support that pain neuroscience education can improve
health status, pain beliefs, illness perceptions, anxiety,
kinesiophobia, and endogenous pain modulation in
several chronic pain populations, including patients with
chronic spinal pain [1,9-14]. Yet, others indicate the
need for more studies to support the clinical utility of
pain neuroscience education [3,4] or that this type of
education is insufficient by itself to change perceived
disability [2,15].
One of the studies indicating the insufficiency of pain
neuroscience education to change perceived disability
comprises the original analysis of the data presented in
this paper [15]. Although there was no change in the
perceived disability in response to pain neuroscience
education, there was an improvement in secondary
outcomes like kinesiophobia, and illness perceptions.
The absence of an effect on perceived disability might
relate to a heterogeneity in the population regarding
symptoms of central sensitization (ie, generalized hy-
persensitivity), as evidence shows more perceived
disability in subgroups that display more symptoms of
central sensitization [16]. Central sensitization is one of
the mechanisms explained during pain neuroscience
education. Therefore, groups with more prominent
symptoms of central sensitization might relate more to
the content and might experience more improvement
regarding perceived disability (and even other outcome
measures) in response to pain neuroscience education.
However, this is merely an assumption that has not been
investigated before, which is the scope of this paper.
Central sensitization is a maladaptive type of neuro-
plasticity that maintains nociceptive hypersensitivity
long after tissue healing has occurred [17], and is
characterized by generalized hypersensitivity of the
somatosensory system [18,19]. Negative or maladaptive
pain related thoughts can facilitate this process [20].
Yet, central sensitization is not the only explanatory
model for chronic spinal pain in literature. Others sug-
gest for example impaired movement, postural control,
and deconditioning as underlying mechanisms for
chronic spinal pain [21-23].
Nevertheless, 3 lines of evidence support the clinical
importance of central sensitization (ie, generalized hy-
persensitivity) in chronic pain patients: (1) compared to
pain patients without signs of central sensitization, pa-
tients with predominant central sensitizationdobjecti-
fied using experimental pain measuresdreport higher
pain severity and lower quality of life [24,25]; (2) central
sensitization relates to poorer prognosis [26-28] and (3) it
mediates treatment outcome after physical rehabilita-
tion [28-30] in various chronic musculoskeletal pain
populations.
One particular instrument that assesses self-reported
symptoms of central sensitization (ie, generalized hy-
persensitivity) is theCentral Sensitization Inventory (CSI).
The CSI evaluates the occurrence of hypersensitivity forFLA 5.5.0 DTD  PMRJ2106_senses unrelated to the musculoskeletal system (eg,
chemical substances, cold, heat, stress, and electrical
stimuli) [31-36], and is a reliable and valid instrument
[37,38]. Still, it needs to be acknowledged that like other
behavior measures of central sensitization in humans (ie,
quantitative sensory testing), the CSI is an indirect mea-
sure of central sensitization. Nevertheless, unlike in ani-
mal studies, there is currently no other way to assess
central sensitization in humans.
The CSI (with the cut-off of >40) has an 81% sensi-
tivity to distinguish between a central sensitivity syn-
drome group and a nonpatient group [39,40], has a
strong connection with psychological distress [41], and
has strong psychometric properties and potential to be a
useful clinical outcome measure [42]. As the content of
pain neuroscience education relates partly on central
sensitization as the underlying mechanism for chronic
pain and explains the influence of psychological distress
on chronic pain, people suffering more from self-
reported symptoms of central sensitization and related
psychological distress might identify more with the
specific content of the education and might therefore
respond better. Identifying groups that respond better
or worse to pain neuroscience education, would enable
clinicians to provide better therapy to patients with
chronic spinal pain.
Because of the ability of pain neuroscience education
to improve several important outcomes in chronic pain
(eg, health status, illness perceptions, kinesiophobia,
etc), the clinical importance of central sensitization (ie,
generalized hypersensitivity) in chronic pain, and the
ability of the CSI to differentiate between patients with
and without self-reported symptoms of central sensiti-
zation, it seems warranted to examine whether patients
with more self-reported symptoms of central sensitiza-
tion respond differently to pain neuroscience education
than those with fewer self-reported symptoms of cen-
tral sensitization. Therefore, this study aimed to
investigate if the effectiveness of pain neuroscience
education (versus biomedical neck/back school) differs
in patients with high and low baseline self-reported
symptoms of central sensitization.
MethodsDesign overviewThis multicenter, triple-blind randomized controlled
trial took place in 2 centers: the University Hospitals of
Ghent and Brussels. The trial was approved by the local
ethics committees (University Hospital Brussels and
University Hospital Ghent) and was conducted between
January 2014 and January 2016. All participants signed
the informed consent. The full study protocol is regis-
tered online (ClinicalTrials.gov NCTxxxxx) and is pub-
lished elsewhere [43]. The trial is reported according to
CONSORT guidelines [44].proof  25 May 2018  4:06 pm  ce





























































































413Here we report the effects of pain neuroscience ed-
ucation (versus biomedical neck/back school as the
control education) on self-reported questionnaires
(assessing disability, catastrophizing, kinesiophobia,
illness perceptions, and hypervigilance) in groups with
high and low self-reported symptoms of central sensi-
tization (ie, generalized hypersensitivity). Outcome



































































480The study population examined in this secondary
analysis is the same as the study population of the
original analysis, which is published elsewhere [15]. One
hundred twenty persons with nonspecific chronic spinal
pain (nCSP) were recruited through different sources:
flyers in the university hospitals in Ghent and Brussels
and primary care practices (medical doctors), via ad-
verts, and via social media.
Participants were found eligible for study participa-
tion if they were (1) native Dutch speaking; (2) aged
between 18 and 65 years; (3) having nCSP at least 3
days/wk for at least 3 months since the first symptoms:
nCSP includes chronic low back pain, failed back surgery
syndrome (ie, more than 3 years ago, anatomically
successful operation without symptom disappearance),
chronic whiplash-associated disorders, and chronic
nontraumatic neck pain; (4) available and willing to
participate in educational sessions; and (5) not
continuing any other therapies (ie, other physical ther-
apy treatments, acupuncture, osteopathy, etc), except
for usual medication.
People were excluded in case of (1) a specific medical
condition, possibly related to their pain (eg, neuro-
pathic pain, a history of neck/back surgery in the past 3
years, osteoporotic vertebral fractures, rheumatologic
diseases); (2) a chronic widespread pain syndromes
diagnosis (eg, fibromyalgia, chronic fatigue syndrome);
(3) having their place of residence more than 50 km
away from the treatment location to avoid dropout
because of practical considerations; and (4) having
received a form of pain neuroscience education in the
past. Additionally, participants were asked not to start
new medication 6 weeks before and during participation
in this study.
Sample size calculations were performed with
G*Power (Du¨sseldorf, Germany) based on the therapy
effects on disability in the pilot study of Van Oos-
terwijck et al. [12] (Cohen d ¼ 0.46; usage of neck
disability index in people with chronic whiplash). Cal-
culations were based on ANOVA repeated measures
(number of measurements ¼ 2; number of groups ¼ 4)
statistics with an effect size of 0.15, alpha set at 0.05,
and a desired power of 0.90, resulting in a total of 164
people.FLA 5.5.0 DTD  PMRJ2106_RandomizationParticipants were randomly assigned into an educa-
tional group, using a stratified permuted block alloca-
tion (block size of 4), with stratification factors being
treatment center (Ghent or Brussels), dominant pain
location (low back or neck), and gender (male or fe-
male) [45,46]. Randomization was performed at the
Biostatistics Unit (Ghent University) by an independent
investigator using SAS 9.4.BlindingThe study participants and the statistician (per-
forming the data analyses) were blinded to the study
hypothesis, and the outcomes assessors (collecting the
data) were blinded for the randomization sequence (ie,
triple blind). Participants did not know whether they
received the experimental or control intervention, and
they did not see each other in the hospital waiting
rooms (no contamination between groups). The thera-
pists providing the experimental treatment were not
involved in the control intervention and vice versa.Subdivision of groupsThe baseline CSI total score was used to divide the
groups based on the presence or absence of self-
reported symptoms of central sensitization (ie, gener-
alized hypersensitivity). This questionnaire consists of
25 items assessing health-related symptoms, rated on a
Likert-scale (0 ¼ “never” to 4 ¼ “always”). The total
score represents the degree of self-reported sympto-
mology (maximum score ¼ 100). A cut-off value of 40 is
determined, with scores higher than 40 indicating the
presence of central sensitization (81% sensitivity and
75% specificity) [40]. Several studies found support for
the reliability and validity of the CSI, including the
Dutch CSI as used here [37-40].Primary Outcome Measure
Pain Disability Index
Pain disability was chosen as the primary outcome
measure because of its importance in people with
chronic spinal pain: perceived disability relates to
employment status, health-related quality of life,
depression, catastrophizing, anxiety, and other psy-
chosocial factors related to well-being [47,48]. The
Dutch version of the Pain Disability Index (PDI) was
used to measure the impact of pain on daily life ac-
tivities. The PDI is a valid measurement tool with good
internal consistency and good test-retest reliability
[49]. Higher scores indicate a higher level of disability
during activities. A change in the PDI is considered
clinically important when it concerns a decrease of
8.5-9.5 points [50].proof  25 May 2018  4:06 pm  ce





















































































































































629Secondary outcome measures were chosen based on
their influence on levels of physical activity, chron-
ification, and participation in daily life and social ac-
tivities [51-54]. Therefore, if an intervention can
improve these outcome measures, it might enhance an
active rehabilitation, which is crucial in the manage-
ment of people with nCSP [55,56].
The Dutch Version of the Pain Catastrophizing Scale
(PCS) assesses catastrophic thoughts regarding pain in
13 statements using a 5-point Likert-type scale (range:
0-52). Summing these scores leads to a total score of 3
subscales: rumination (4 statements, score range: 0-16),
magnification (3 statements, score range: 0-12), and
helplessness (6 statements, range: score 0-24). Higher
scores indicate a higher degree of catastrophic thoughts
regarding pain [57]. The PCS has adequate reliability in
people with musculoskeletal disorders [58] and has good
criterion and construct validity [58,59].
The Dutch version of the Tampa Scale for Kinesi-
ophobia (TSK) contains 17 statements regarding fear of
movement or (re)injury, each scored on a 4-point Likert-
type scale (range: 17-68). Higher scores indicate higher
fear of movement [60,61], and the minimal clinical
important difference is determined as a change of 6
points [62]. The TSK has a moderate construct validity
and excellent test-retest reliability [61,63].
The Dutch version of the Revised Illness Perception
Questionnaire (IPQr) measures several dimensions of
illness perceptions: beliefs about the course of their
chronic pain (score range: 0-25) and the time scale of
illness symptoms (score range: 0-20), the impact of the
illness on quality of life and functional capacity (score
range: 0-30), the perceived influence of own behavior
(score range: 0-30) and treatment efficacy (score
range: 0-25), the emotional responses (score range:
0-30), and the coherent understanding (score range:
0-25) of the illness [64,65]. All items are scored on a
5-point Likert-type scale. The IPQr has a good test-
retest reliability and predictive validity in different
patient populations [65].
The Dutch version of the Pain Vigilance and Aware-
ness Questionnaire (PVAQ) measures the patient’s
awareness of and attention to pain in 16-items (range:
0-80). Higher scores indicate a higher degree of pain
vigilance and awareness. The PVAQ has good internal
consistency and test-retest reliability and is shown valid










640All study participants received 3 educational sessions
within 2 weeks. The format of administration was
identical for both treatment groups. The first session
was a group educational session (PowerPoint presenta-
tion, duration: 30 minutes to 1 hour; maximal 6FLA 5.5.0 DTD  PMRJ2106_participants/group) led by a physical therapist with
clinical experience in chronic spinal pain. The therapist
delivering education in one group did not provide edu-
cation in the other group, and vice versa. Afterwards,
participants received an educational booklet containing
the same information to read at home. The second
session was an online home-based e-learning module,
containing 3 explanatory videos. These videos displayed
the PowerPoint presentation used in the group session,
with a voice-over explaining the content of the slides.
After each video, the participants had to complete a
questionnaire that assessed their opinion and under-
standing of that video. The third session comprised a
30-minute one-on-one conversation focusing on the
patient’s personal needs: answers from the second
session’s questionnaires were analyzed and the appli-
cation of the newly derived knowledge into daily life
was discussed. The content of the provided education
(described below) rather than the format of adminis-
tration differed between groups.
Experimental group
The content and pictures of the first and the second
session were based on current knowledge of the
neurophysiology of pain [69] and on 2 instructive books
[6,7]. An example of a PowerPoint presentation for pain
neuroscience education can be found online (http://
www.paininmotion.be/storage/app/media//materials/
sem-PainPhysiologyEducationEnglish.pdf).
Following topics are covered: the physiology of the
(1) the neuron (receptor, axon, terminal), (2) the syn-
apse (action potential, neurotransmitters, postsynaptic
membrane potential, chemically driven ion channel),
(3) descending nociceptive inhibition and facilitation
(the influence of stress, emotions, thoughts, physical
activity, etc), (4) peripheral sensitization, and (5) cen-
tral sensitization (receptor field growth, potentiation of
the postsynaptic membrane, changes at cortical and
subcortical level, etc).
In the third session, the therapist and patient dis-
cussed the answers given during the online session by
relating them to the pain neuroscience education con-
tent. After these 3 sessions, the patients should be able
to put their pain into the right perspective and to feel
less threatened by the pain, leading to the willingness to
perform physical activity with progression towards
feared or avoided movements.
Control group
The biomedically focused neck/back school was
based on available clinical guidelines [70,71]. Partici-
pants were expected gain biomedically oriented
knowledge on neck and low back pain during the edu-
cation. The following topics were covered: (1) the
normal course and mechanical causes of neck/back
pain; (2) the anatomy, physiology, and biomechanics of
the spinal bones, joints, and muscles; (3) ergonomicproof  25 May 2018  4:06 pm  ce

































































































737advice and the importance of self-care; (4) lifting
techniques (using pictures of people lifting in several
ways); and (5) the value of and principles behind
different types of exercises (stretching, and strength,
endurance, and fitness training). It did not include in-
formation on the nervous system, except for the course
and location of the spinal cord and spinal nerve roots.
During the third session, the patient and therapist dis-
cussed the answers given during the online session by
relating them to the content of the education, and pa-
tients were given ergonomic advice for specific activ-











































781Data were analyzed using SPSS 22.0. Subjects of both
educational groups were allocated into groups based on
their baseline CSI scores. Subjects with a CSI score
higher than 40 were allocated into the high-CSI group,
and the others into the low-CSI group, leading to a total
of 4 groups. Differences in response to the interventions
between the 4 groups were first analyzed using analysis
of covariance, with gender as covariate. As this covari-
ate did not show significant interaction in any variable,
the analysis was performed again without this covariate.
The assumption of homogeneity and sphericity was
checked by Levene’s and Mauchly’s test, respectively.
When the assumption of sphericity was violated,
Greenhouse-Geisser corrections were used. In case of
significant interaction effects (ie, implying that the
compared groups respond differently to the interven-
tion given), Bonferroni post hoc analysis was carried out
to investigate the specific differences within and be-
tween groups. Data were analyzed according to the
intention-to-treat principle (ie, the first-observation-
carried-forward method). This method was used
because of the short period (2 weeks) between the
baseline and posteducation measurements. Therefore,
we believe that the baseline measurement is most
representative as follow-up measurement for the peo-
ple who dropped out. Also, we are aware that this



















800Of the 120 persons included, 9 (n ¼ 2 in the high-CSI
neck/back school group; n ¼ 2 in the low-CSI neck/back
school group; n ¼ 2 in the high-CSI pain neuroscience
education group; and n ¼ 3 in the low-CSI pain neuro-
science education group) dropped out before comple-
tion of the second round of questionnaires. Reasons for
dropout are outlined in the study flow chart (Figure 1).FLA 5.5.0 DTD  PMRJ2106_Subjects’ baseline characteristics can be found in detail
in Table 1.Effectiveness of Pain Neuroscience Education in
Patients With nCSP With High and Low Self-
Reported Symptoms of Central SensitizationRegarding pain disability, no significant interaction
effect was found (Table 2), but differences at group
level (P < .001) were found. All patients with high CSI
scores had higher PDI scores than the groups with low
CSI scores (P < .004 for all comparisons; see Table 3).
For all pain catastrophizing items (except for help-
lessness), significant interaction effects were found
(P values ranging from P ¼ .02 to P ¼ .05; see Table 2 and
Figure 2). Bonferroni post hoc analysis (Table 3 and
Figure 2) showed a significant difference at baseline
between the 2 pain neuroscience education groups
(mean difference rumination: 4.07, 95% CI: 2.06-6.07;
mean difference magnification: 2.17, 95% CI: 1.07-3.26;
mean difference total score: 9.67, 95% CI: 4.74-14.60)
and that these 3 pain catastrophizing items decreased
significantly only in the high-CSI pain neuroscience ed-
ucation group (P < .001; small effect sizes), which was
not seen in the low-CSI groups (negligible sizes). Sur-
prisingly, PCS magnification increased in the low-CSI
pain neuroscience education group (P ¼ .03; small ef-
fect size).
Regarding kinesiophobia, a significant interaction
effect was found (P ¼ .02; see Table 2 and Figure 3).
Bonferroni post hoc analysis showed that only in the
pain neuroscience education groups kinesiophobia
decreased significantly (P < .001, medium effect sizes;
see Table 3 and Figure 3). Additional analysis of group
effects showed significantly higher kinesiophobia at
baseline in the high-CSI pain neuroscience education
group compared to the low-CSI group (P ¼ .02). Post-
education, there was a significant group difference be-
tween the high-CSI groups (P ¼ .03) and the low-CSI
groups (P ¼ .001).
Last, several illness perceptions showed significant
interaction effects (see Table 2 and Figures 4 and 5):
acute/chronic timeline (P ¼ .002), negative conse-
quences (P ¼ .02), personal control (P ¼ .02), and
timeline cyclical (P ¼ .012). Bonferroni post hoc analysis
(Table 3) showed that both pain neuroscience education
groups improved significantly posteducation for all
subscales (P values ranging from <.001-.01, small to
large effect sizes). In the neck/back school groups,
there was a significant improvement of IPQr “acute/
chronic timeline” (P < .001; medium effect size) in the
low-CSI group and a significant improvement of IPQr
“personal control” (P < .001; medium effect size) in the
high-CSI group. Bonferroni post hoc analyses of group
effects (Table 3) showed significantly higher IPQr con-
sequences scores in the high-CSI pain neuroscience ed-
ucation group compared to the low-CSI painproof  25 May 2018  4:06 pm  ce
Figure 1. Study flow chart. CSI ¼ Central Sensitization Inventory. Q7
































































































































































960neuroscience education group at baseline (P < .001) and
posteducation (P < .001).
Discussion
The aim of this study was to investigate if the effec-
tiveness of pain neuroscience educationdcompared to
biomedical neck/back schoolddiffers between patients
with high and low self-reported symptoms of centralFLA 5.5.0 DTD  PMRJ2106_sensitization (ie, generalized hypersensitivity). Results of
the present study show that pain neuroscience education
is superior over neck/back school for improving kinesi-
ophobia and the perceived negative consequences and
cyclicity of the illness in patients with nCSP regardless
their baseline self-reported symptoms of central sensiti-
zation. Yet, only in patients with high self-reported
symptoms of central sensitization, pain neuroscience ed-
ucationhas thepotential to reduce ruminationabout pain.proof  25 May 2018  4:06 pm  ce
Table 1
Demographics and baseline characteristics of patients with nCSP with high and low self-reported signs of central sensitization
Demographic Characteristics
Pain Neuroscience Education Neck/Back School
High CSI (n ¼ 24) Low CSI (n ¼ 36) High CSI (n ¼ 30) Low CSI (n ¼ 30)
Demographics
Dominant pain problem,* NP/LBP 13/11 19/17 17/13 15/15
Sex, F/M 17/7 21/15 22/8 13/17
Duration of pain,† mo 111 (128.3) 88 (156.5) 66.5 (96.5) 70.5 (141.5)
Educational Level*
No degreLower second.eHigher second.eHigher Edu
0e1e7e16 0e3e4e29 0e5e7e18 0e3e6e21
Working hours per week† 40 (12.50) 39 (15.75) 38 (23.75) 40 (12.50)
Age, y‡ 36.58  11.03 40.47  12.49 40.13  14.91 42.10  11.10
Age, y, min-max 20-56 20-65 19-65 19-64
Baseline characteristics
PDI (n ¼ 70) 30.13  14.92 16.25  11.59 26.03  15.06 17.13  9.94
PCS: Rumination (n ¼ 16) 8.96  3.37 4.89  3.78 7.63  4.26 5.37  3.85
PCS: Magnification (n ¼ 12) 3.75  2.25 1.58  1.70 3.23  2.40 2.27  2.08
PCS: Helplessness (n ¼ 24) 9.63  4.39 6.19  4.33 8.73  5.98 6.47  4.31
PCS Total (n ¼ 52) 22.33  8.50 12.67  8.62 19.60  11.33 14.10  9.05
TSK (n ¼ 68) 37.00  6.76 32.61  6.84 37.97  6.71 35.47  6.86
IPQr: Acute/Chronic Timeline (n ¼ 25) 24.63  4.13 23.33  4.19 23.13  3.58 23.33  3.70
IPQr: Consequences (n ¼ 20) 19.50  4.29 14.53  4.33 18.00  3.94 15.30  4.77
IPQr: Personal Control (n ¼ 30) 19.33  4.01 20.75  4.13 19.43  4.35 22.27  3.61
IPQr: Treatment Control (n ¼ 30) 16.42  2.34 17.11  2.69 16.63  3.43 17.83  2.25
IPQr: Illness Coherence (n ¼ 25) 16.88  1.96 17.17  2.79 15.63  2.71 17.27  2.15
IPQr: Timeline Cyclical (n ¼ 30) 12.83  3.05 13.28  3.64 12.53  2.62 13.80  3.25
IPQr: Emotional Representations (n ¼ 25) 17.21  3.88 13.42  3.87 15.67  4.77 13.40  5.44
PVAQ (n ¼ 60) 40.88  9.18 34.25  12.88 36.10  10.45 35.43  14.72
nCSP ¼ nonspecific chronic spinal pain; CSI ¼ Central Sensitization Inventory; NP ¼ neck pain; LBP ¼ low back pain; F ¼ female; M ¼ male; No
degr¼ no degree; Lower second¼ lower secondary; Higher second¼ higher secondary; Higher edu ¼ higher education; PDI¼ Pain Disability index;
PCS ¼ Pain Catastrophizing Scale; TSK ¼ Tampa Scale for Kinesiophobia; IPQr ¼ Illness Perception Questionnaire revised; PVAQ ¼ Pain Vigilance
and Awareness Questionnaire.
* Categorical data presented as frequencies.
† Values are presented as median (Interquartile range) for continuous data that were observed as not normally distributed.
‡ Values are presented as mean  standard deviation for continuous normal distributed data.
































































































































































1120The use of CSI scores to subgroup the participants in
this study and its relevance to measure central sensiti-
zation should be discussed. Like other behavioral mea-
sures, the CSI is an indirect tool to measure central
sensitization and based on the recently proposed clin-
ical classification system for central sensitization pain
[72,73], CSI scores alone are insufficient to differentiate
between self-reported symptoms of central sensitiza-
tion and noncentral sensitization pain. Although the CSI
cannot directly objectify central sensitization, the
questionnaire is related to psychological distress and
widespread pain, and is therefore related to central
sensitization [41]. Because of the shared variance be-
tween the CSI and psychological distress, it is possible
that the latter predicts the outcome following pain
neuroscience education in patients with nCSP, rather
than central sensitization. Nevertheless, the CSI is an
easy-to-use and clinically relevant tool and was there-
fore used as such in this study to generate clinically
applicable results.
The a priori defined primary outcome measuredpain
disabilityddid not change in any of the study groups,
while previous studies on pain neuroscience education
did report a positive effect on self-reported disabilityFLA 5.5.0 DTD  PMRJ2106_[2,12,74]. That discrepancy could beexplaineddue to the
use of a different questionnaire to objectify disability, for
example, the Roland Morris Disability Questionnaire
[2,74] and the Neck Disability Index [12]. Other expla-
nations may involve the use of an uncontrolled study
design in earlier studies [12] or because the investigated
patient population of this study comprises both patients
with low back pain and neck pain, while previous studies
focused on either low back pain or neck pain patients.
Results regarding pain catastrophizing indicate that
pain catastrophizing in general, and rumination in
particular are 2 aspects that can be targeted primarily
in patients with high baseline self-reported symptoms of
central sensitization using pain neuroscience education
(small effect sizes). Neck/back school is not able to
alter pain rumination, but the total pain catastrophizing
score did improve in the neck/back school group with
high self-reported symptoms of central sensitization.
This, combined with the improvement in the total score
in the pain neuroscience education group, indicates that
patients with high self-reported symptoms of central
sensitization seem to benefit more from educational
sessions than patients with low levels, regardless the
information provided.proof  25 May 2018  4:06 pm  ce
Table 2




























PDI (n ¼ 70) Baseline 30.09 (2.70) 16.25 (2.16) 13.84 [6.99, 20.68] 26.03 (2.16) 17.13 (2.36) 8.90 [2.28, 15.52] F ¼ 1.414
P ¼ .24
F ¼ 9.580
P<.001Post Edu 27.65 (2.41) 16.58 (1.93) 11.07 [4.96, 17.18] 28.53 (2.11) 16.93 (2.11) 11.60 [5.69, 17.51]
ES Cohen d 0.19 0.03 d 0.21 0.02 d
Secondary outcome measures
PCS: Rumination (n ¼ 16) Baseline 8.96 (0.79) 4.89 (0.64) 4.07 [2.06, 6.07] 7.63 (0.70) 5.37 (0.70) 2.27 [0.30, 4.23] F ¼ 2.759
P [ .05
N/A
Post Edu 7.21 (0.78) 5.33 (0.64) 1.88 [e0.11, 3.86] 6.67 (0.70) 4.77 (0.70) 1.90 [e0.05, 3.85]
ES Cohen d 0.46 0.11 d <0.01 0.16 d
PCS: Magnification (n ¼ 12) Baseline 3.75 (0.43) 1.58 (0.35) 2.17 [1.07, 3.26] 3.23 (0.38) 2.27 (0.38) 0.97 [e0.11, 2.04] F ¼ 3.349
P [ .02
N/A
Post Edu 2.83 (0.43) 2.36 (0.35) 0.47 [e0.63, 1.58] 2.87 (0.39) 1.93 (0.39) 0.93 [e0.15, 2.02]
ES Cohen d 0.44 0.37 d 0.17 0.16 d
PCS: Helplessness (n ¼ 24) Baseline 9.63 (0.98) 6.19 (0.80) 3.43 [0.92, 5.94] 8.73 (0.88) 6.47 (0.88) 2.27 [e0.19, 4.72] F ¼ 1.189
P ¼ .32
F ¼ 2.633
P ¼ .05Post Edu 7.96 (0.99) 5.92 (0.80) 2.04 [e0.48, 4.56] 7.47 (0.88) 5.87 (0.88) 1.60 [e0.87, 4.07]
ES Cohen d 0.35 0.06 d 0.26 0.12 d
PCS: Total Score (n ¼ 52) Baseline 22.33 (1.93) 12.37 (1.58) 9.67 [4.74, 14.60] 19.60 (1.73) 14.10 (1.73) 5.50 [0.67, 10.33] F ¼ 3.487
P [ .02
N/A
Post Edu 18.00 (1.93) 13.61 (1.57) 4.39 [e0.54, 9.31] 17.00 (1.72) 12.57 (1.72) 4.43 [e0.39, 9.26]
ES Cohen d 0.46 0.13 d 0.28 0.16 d
TSK (n ¼ 68) Baseline 37.00 (1.39) 32.61 (1.13) 4.39 [0.84, 7.34] 37.97 (1.24) 35.47 (1.24) 2.50 [e0.98, 5.98] F ¼ 3.651
P [ .02
N/A
Post Edu 32.25 (1.43) 29.03 (1.17) 3.22 [e0.43, 6.88] 36.53 (1.28) 34.93 (1.28) 1.60 [e1.98, 5.18]
ES Cohen d 0.69 0.52 d 0.21 0.08 d
IPQr: Acute/chronic
Timeline (n ¼ 25)
Baseline 24.63 (0.80) 23.33 (0.65) 1.29 [e0.75, 3.33] 23.13 (0.71) 23.33 (0.71) e0.20 [e2.20, 1.80] F ¼ 5.207
P [ .002
N/A
Post Edu 20.58 (0.93) 19.47 (0.76) 1.11 [e1.26, 3.49] 22.17 (0.83) 21.00 (0.83) 1.17 [e1.16, 3.49]
ES Cohen d 0.95 0.91 d 0.23 0.55 d
IPQr: Consequence (n ¼ 20) Baseline 19.50 (0.89) 14.53 (0.72) 4.97 [2.70, 7.24] 18.00 (0.79) 15.30 (0.79) 2.70 [0.48, 4.92] F ¼ 3.429
P [ .02
N/A
Post Edu 16.96 (0.84) 12.94 (0.69) 4.01 [1.87, 6.16] 17.90 (0.75) 15.00 (0.75) 2.90 [0.80, 5.00]
ES Cohen d 0.60 0.38 d 0.02 0.07 d
IPQr: Personal Control (n ¼ 30) Baseline 19.33 (0.83) 20.75 (0.67) e1.42 [e3.53, 0.69] 19.43 (0.74) 22.27 (0.74) e2.83 [e4.90, e0.77] F ¼ 3.577
P [ .02
N/A
Post Edu 22.50 (0.63) 22.39 (0.51) 0.11 [e1.49, 1.72] 21.87 (0.56) 22.43 (0.56) e0.57 [e2.14, 1.01]
ES Cohen d 0.88 0.46 d 0.68 0.04 d
IPQr: Treatment control (n ¼ 30) Baseline 16.42 (0.56) 17.11 (0.46) e0.69 [e2.12, 0.73] 16.63 (0.50) 17.83 (0.50) e1.20 [e2.60, 0.20] F ¼ 0.739
P ¼ .53
F ¼ 1.916
P ¼ .13Post Edu 17.75 (0.45) 18.03 (0.37) e0.28 [e1.42, 0.87] 17.07 (0.40) 18.30 (0.40) e1.23 [e2.35, e0.11]
ES Cohen d 0.53 0.37 d 0.18 0.19 d
IPQr: Illness Coherence (n ¼ 25) Baseline 16.88 (0.50) 17.17 (0.41) e0.29 [e1.58, 1.00] 15.63 (0.45) 17.27 (0.45) e1.63 [e2.90, e0.37] F ¼ 1.518
P ¼ .21
F ¼ 3.544
P [ .02Post Edu 18.17 (0.52) 17.19 (0.42) 0.97 [e0.35, 2.30] 16.30 (0.46) 18.07 (0.46) e1.77 [e3.07, e0.47]
ES Cohen d 0.52 0.01 d 0.27 0.32 d
IPQr: Timeline Cyclical (n ¼ 30) Baseline 12.83 (0.65) 13.28 (0.53) e0.44 [e2.11, 1.22] 12.53 (0.58) 13.80 (0.58) e1.27 [e2.90, 0.37] F ¼ 3.585
P [ .02
N/A
Post Edu 14.17 (0.67) 14.42 (0.54) e0.25 [e1.95, 1.45] 12.77 (0.60) 13.13 (0.60) e0.37 [e2.04, 1.30]
ES Cohen d 0.41 0.36 d 0.07 0.21 d
IPQr: Emotional Representations
(n ¼ 25)
Baseline 17.21 (0.93) 13.42 (0.76) 3.79 [1.42, 6.16] 15.67 (0.83) 13.40 (0.83) 2.27 [e0.05, 4.59] F ¼ 0.336
P ¼ .78
F ¼ 4.330
P [ .006Post Edu 17.04 (0.95) 14.19 (0.77) 2.85 [0.43, 5.27] 16.00 (0.85) 13.93 (0.85) 2.07 [e0.31, 4.44]
ES Cohen d 0.04 0.17 d 0.07 0.12 d
PVAQ (n ¼ 60) Baseline 40.88 (2.49) 34.25 (2.03) 6.63 [0.27, 12.98] 36.10 (2.22) 35.43 (2.22) 0.67 [e5.56, 6.89] F ¼ 1.272
P ¼ .29
F ¼ 0.930
P ¼ .43Post Edu 35.38 (2.50) 32.61 (2.04) 2.76 [e3.62, 9.15] 34.97 (2.23) 32.60 (2.23) 2.37 [e0.89, 8.62]
ES Cohen d 0.45 0.13 d 0.09 0.23 d
ANOVA repeated measures analysis. Significant results and large effect sizes are printed in bold. Effect sizes were calculated as Cohen d. Cohen d is interpreted as very large (>1.3), large (0.80-1.29), medium
(0.50-0.79), small (0.20-0.49), and negligible (<0.20).
nCSP ¼ nonspecific chronic spinal pain; ANOVA ¼ analysis of variance; CSI ¼ Central Sensitization Inventory; SE ¼ standard error; CI ¼ confidence interval; PDI ¼ Pain Disability Index; Post Edu ¼ post education;


























































































































































































































Results of Bonferroni post hoc analysis of the significant interaction effects after PNE versus NBS in patients with chronic spinal pain (n ¼ 120) with
high and low scores on the CSI
Questionnaire
Effect of Group, P Value
Effect of Time, P ValueHigh-CSI PNE vs Low-CSI PNE High-CSI PNE vs High-CSI NBS Low-CSI PNE vs Low-CSI NBS
PCS Rumination Baseline .001 Baseline .21 Baseline .62 PNE .005*, .38†
Post Edu .06 Post Edu .60 Post Edu .55 NBS .08‡, .28§
PCS Magnification Baseline .001 Baseline .37 Baseline .19 PNE .04*, .03†
Post Edu .40 Post Edu .95 Post Edu 42 NBS .36‡, .40§
PCS Total Score Baseline .001 Baseline .29 Baseline .54 PNE .001*, .39†
Post Edu .08 Post Edu .70 Post Edu 66 NBS .03‡, .20§
TSK Baseline .02 Baseline .61 Baseline .09 PNE .001*, .001†
Post Edu .08 Post Edu .03 Post Edu .001 NBS .15‡, .59§
IPQr Acute/chronic
Timeline
Baseline .21 Baseline .17 Baseline .99 PNE .001*, .001†
Post Edu .36 Post Edu .21 Post Edu .18 NBS .13‡, .001§
IPQr Consequence Baseline .001 Baseline .21 Baseline .47 PNE .001*, .004†
Post Edu .001 Post Edu .40 Post Edu .05 NBS .87‡, .61§
IPQr Personal Control Baseline .19 Baseline .93 Baseline .13 PNE .001*, .007†
Post Edu .891 Post Edu .454 Post Edu .953 NBS .001‡, .80§
IPQr Timeline Cyclical Baseline .598 Baseline .732 Baseline .510 PNE .01*, .01†
Post Edu .772 Post Edu .120 Post Edu .114 NBS .63‡, .17§
Bonferroni post hoc analysis of significant interaction effects. Significant P values are printed in bold.
PNE ¼ pain neuroscience education; NBS ¼ neck/back school; CSI ¼ Central Sensitization Inventory; PCS ¼ Pain Catastrophizing Scale; Post
Edu ¼ post education; TSK ¼ Tampa Scale for Kinesiophobia; IPQr ¼ Illness Perception Questionnaire revised.
* Effect of time in the Pain Neuroscience Education group with high CSI levels.
† Effect of time in the Pain Neuroscience Education group with low CSI levels.
‡ Effect of time in the Neck/Back School Group with high CSI levels.






































































































































































1417Pain magnification on the contrary, can be reduced
by pain neuroscience education in patients with high
self-reported symptoms of central sensitization (small
effect size), while it tends to increase in patients with
low self-reported symptoms of central sensitization
(small effect size). Therefore, one should be cautious
while explaining pain neurophysiology to nCSP patients
with low self-reported symptoms of central sensitization
to make sure the information provided does not lead to
magnification of the pain problem. While providing pain
neuroscience education, the therapist should clearly
assess the patients’ thoughts on the delivered infor-
mation and address inappropriate beliefs upon
occurrence.Figure 2. The effect of pain neuroscience education versus neck/back scho
and low baseline CSI levels (n ¼ 120). Overall significant interaction effects
(post hoc Bonferroni) are displayed behind the respective groups using an a
(post hoc Bonferroni) are displayed as P values. PCS ¼ Pain Catastrophizin
FLA 5.5.0 DTD  PMRJ2106_Regarding kinesiophobia, medium effect sizes are
found in both pain neuroscience education groups, while
effect sizes remain small to negligible in the neck/back
school group. This finding is consistent with previous
research [2,12,74]. However, previous research did not
account for the presence of self-reported symptoms of
central sensitization. The results of this study indicate
that for kinesiophobia, baseline self-reported symptoms
of central sensitization did not influence the effect of
pain neuroscience education as both groups improved
equally (medium effect sizes). The decrease in kinesi-
ophobia is a positive effect directly resulting from pain
neuroscience education as this was not seen in the neck/
back school group. This is an important finding asol on pain catastrophizing in patients with chronic spinal pain with high
are displayed in the figure using a box. Significant within-group effects
sterisk (*P<.05, **P<.01, ***P<.001). Significant between-group effects
g Scale; CSI ¼ Central Sensitization Inventory.




















































Figure 3. Pain neuroscience education is effective for decreasing
kinesiophobia regardless self-reported signs of central sensitization,
compared to neck/back school, in patients with chronic spinal pain
(n ¼ 120). Overall significant interaction effects are displayed in the
figure using a box. Significant within-group effects (post hoc Bonfer-
roni) are displayed behind the respective groups using an asterisk
(*P<.05, **P<.01, ***P<.001). Significant between-group effects (post
hoc Bonferroni) are displayed as P values. TSK ¼ Tampa Scale for































































































































































1570kinesiophobia is a strong predictor for chronification
[75], and a decrease is shown to be related to greater
improvement in pain and disability [76].
Kinesiophobia can occur from an ignorance regarding
pain symptoms [77]. Patients with chronic pain may
believe that their pain is related to tissue damage,
whereas evidence shows that spinal radiologic imaging
findings are often unrelated to spinal pain [78]. Pain
neuroscience education helps patients to understand the
mechanisms underlying the pain problem by explaining
that pain is the result of sensory hypersensitivity ratherFigure 4. The effect of pain neuroscience education and neck/back school
patients with chronic spinal pain with high and low baseline CSI levels (n ¼
using a box. Significant within-group effects (post hoc Bonferroni) are disp
***P<.001). Significant between-group effects (post hoc Bonferroni) are d
CSI ¼ Central Sensitization Inventory.
FLA 5.5.0 DTD  PMRJ2106_than a damaged spine. This knowledge may result in
reduced fear of injury or damage while moving the spine,
possibly resulting in a decrease in kinesiophobia.
In addition, interesting findings regarding illness
perceptions were noted. For all aspects of illness per-
ceptions that showed significant interaction effects,
both groups with high and low baseline self-reported
symptoms of central sensitization improved in
response to pain neuroscience education. This implies
that pain neuroscience education is able to reduce the
perceived chronicity and the perceived negative impact
of the illness, whereas it can increase the perceived
fluctuations of the illness and the perceived personal
control. This is not an unexpected finding as pain
neuroscience education imparts a change in illness
perceptions by redefining pain. Also, the increase in the
aspect “timeline cyclical” does not come as a surprise.
This indicates that pain neuroscience education leads to
stronger beliefs of unpredictability and cyclicity of the
illness, which should be interpreted with respect to the
content of the education. Patients learn that the normal
course of chronic pain is fluctuating and unpredictable.
Therefore, a significant increase in this subscale could
represent the increased knowledge and acceptance.Strengths and LimitationsStudy strengths include the balanced treatment
arms, triple-blind randomized design, use of reliable
and valid outcomes and the a priori study protocol
publication [43].
Also, some limitations should be mentioned. The lack
of follow-up period is an important limitation of this
study as information retention and delayed changes in
the investigated outcome measures were not evaluated.on the perceived chronicity and negative consequences of the illness in
120). Overall significant interaction effects are displayed in the figure
layed behind the respective groups using an asterisk (*P<.05, **P<.01,
isplayed as P-values. IPQr ¼ Illness Perception Questionnaire revised;




























































Figure 5. The effect of pain neuroscience education and neck/back school on the perceived personal control on and the cyclicity of the illness in
patients with chronic spinal pain with high and low baseline CSI levels (n ¼ 120). Overall significant interaction effects are displayed in the figure
using a box. Significant within-group effects (post hoc Bonferroni) are displayed behind the respective groups using an asterisk (*P<.05, **P<.01,
***P<.001). Significant between-group effects (post hoc Bonferroni) are displayed as P values. IPQr ¼ Illness Perception Questionnaire revised;
CSI ¼ Central Sensitization Inventory.
Supplementary Data
Supplementary data associated with this article can
be found in the online version at https://doi.org/10.
1016/j.pmrj.2018.04.010.































































































































1727Furthermore, one should be cautious in extrapolating
these results into the general chronic pain population
given the heterogeneity of this group.
A last limitation to consider relates to the sample size
calculation, which indicated the inclusion of 164 study
participants (accounting for 2 measurements and 4
groups). However, as this study entails a secondary
analysis of a data set that included only 120 study par-
ticipants, we failed to meet this sample size (n ¼ 164).



























To conclude, results indicate that pain neuroscience
education is superior to neck/back school in improving
kinesiophobia and the perceived negative consequences
and cyclicity of the illness in patients with nCSP
regardless their baseline self-reported symptoms of
central sensitization (ie, generalized hypersensitivity).
Only in patients with high self-reported symptoms of
central sensitization does pain neuroscience education
have the potential to reduce rumination about pain, a
result that is not seen in patients with low self-reported
symptoms of central sensitization. In general, these
results imply the use of pain neuroscience education
over neck/back school in clinical practice in patients
with nCSP regardless their baseline levels of self-
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Supplementary Online Table S1
Post hoc analysis of significant main effects of group
Questionnaires













PDI .001 >.99 .002 .001 >.99 .004
IPQr: Illness Coherence .10 .07 >.99 .18 >.99 .02
IPQr: Emotional Representations .002 >.99 .02 .33 >.99 .30
Bonferroni post hoc analysis of significant main effects of group. Significant P values are printed in bold.
CSI ¼ Central Sensitization Inventory; PNE ¼ pain neuroscience education; NBS ¼ neck/back school; PDI ¼ Pain Disability Index; IPQr ¼ Illness
Perception Questionnaire revised.
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